The global Respiratory Distress Syndrome market size was valued at US$ 369.5 million in 2023. With growing demand in downstream market, the Respiratory Distress Syndrome is forecast to a readjusted size of US$ 544.9 million by 2030 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Respiratory Distress Syndrome market. Respiratory Distress Syndrome are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Respiratory Distress Syndrome. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Respiratory Distress Syndrome market.
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks鈥� gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
Key Features:
The report on Respiratory Distress Syndrome market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Respiratory Distress Syndrome market. It may include historical data, market segmentation by Type (e.g., Poractant Alfa, Beractant), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Respiratory Distress Syndrome market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Respiratory Distress Syndrome market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Respiratory Distress Syndrome industry. This include advancements in Respiratory Distress Syndrome technology, Respiratory Distress Syndrome new entrants, Respiratory Distress Syndrome new investment, and other innovations that are shaping the future of Respiratory Distress Syndrome.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Respiratory Distress Syndrome market. It includes factors influencing customer ' purchasing decisions, preferences for Respiratory Distress Syndrome product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Respiratory Distress Syndrome market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Respiratory Distress Syndrome market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Respiratory Distress Syndrome market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Respiratory Distress Syndrome industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Respiratory Distress Syndrome market.
Market Segmentation:
Respiratory Distress Syndrome market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Poractant Alfa
Beractant
Calfactant
Others
Segmentation by application
Very Preterm Infants
Moderate to Late Preterm Infants
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Respiratory Distress Syndrome Market Size 2019-2030
2.1.2 Respiratory Distress Syndrome Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Respiratory Distress Syndrome Segment by Type
2.2.1 Poractant Alfa
2.2.2 Beractant
2.2.3 Calfactant
2.2.4 Others
2.3 Respiratory Distress Syndrome Market Size by Type
2.3.1 Respiratory Distress Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Respiratory Distress Syndrome Market Size Market Share by Type (2019-2024)
2.4 Respiratory Distress Syndrome Segment by Application
2.4.1 Very Preterm Infants
2.4.2 Moderate to Late Preterm Infants
2.4.3 Others
2.5 Respiratory Distress Syndrome Market Size by Application
2.5.1 Respiratory Distress Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Respiratory Distress Syndrome Market Size Market Share by Application (2019-2024)
3 Respiratory Distress Syndrome Market Size by Player
3.1 Respiratory Distress Syndrome Market Size Market Share by Players
3.1.1 Global Respiratory Distress Syndrome Revenue by Players (2019-2024)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Respiratory Distress Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Respiratory Distress Syndrome by Regions
4.1 Respiratory Distress Syndrome Market Size by Regions (2019-2024)
4.2 Americas Respiratory Distress Syndrome Market Size Growth (2019-2024)
4.3 APAC Respiratory Distress Syndrome Market Size Growth (2019-2024)
4.4 Europe Respiratory Distress Syndrome Market Size Growth (2019-2024)
4.5 Middle East & Africa Respiratory Distress Syndrome Market Size Growth (2019-2024)
5 Americas
5.1 Americas Respiratory Distress Syndrome Market Size by Country (2019-2024)
5.2 Americas Respiratory Distress Syndrome Market Size by Type (2019-2024)
5.3 Americas Respiratory Distress Syndrome Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Distress Syndrome Market Size by Region (2019-2024)
6.2 APAC Respiratory Distress Syndrome Market Size by Type (2019-2024)
6.3 APAC Respiratory Distress Syndrome Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Respiratory Distress Syndrome by Country (2019-2024)
7.2 Europe Respiratory Distress Syndrome Market Size by Type (2019-2024)
7.3 Europe Respiratory Distress Syndrome Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Respiratory Distress Syndrome by Region (2019-2024)
8.2 Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2019-2024)
8.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Respiratory Distress Syndrome Market Forecast
10.1 Global Respiratory Distress Syndrome Forecast by Regions (2025-2030)
10.1.1 Global Respiratory Distress Syndrome Forecast by Regions (2025-2030)
10.1.2 Americas Respiratory Distress Syndrome Forecast
10.1.3 APAC Respiratory Distress Syndrome Forecast
10.1.4 Europe Respiratory Distress Syndrome Forecast
10.1.5 Middle East & Africa Respiratory Distress Syndrome Forecast
10.2 Americas Respiratory Distress Syndrome Forecast by Country (2025-2030)
10.2.1 United States Respiratory Distress Syndrome Market Forecast
10.2.2 Canada Respiratory Distress Syndrome Market Forecast
10.2.3 Mexico Respiratory Distress Syndrome Market Forecast
10.2.4 Brazil Respiratory Distress Syndrome Market Forecast
10.3 APAC Respiratory Distress Syndrome Forecast by Region (2025-2030)
10.3.1 China Respiratory Distress Syndrome Market Forecast
10.3.2 Japan Respiratory Distress Syndrome Market Forecast
10.3.3 Korea Respiratory Distress Syndrome Market Forecast
10.3.4 Southeast Asia Respiratory Distress Syndrome Market Forecast
10.3.5 India Respiratory Distress Syndrome Market Forecast
10.3.6 Australia Respiratory Distress Syndrome Market Forecast
10.4 Europe Respiratory Distress Syndrome Forecast by Country (2025-2030)
10.4.1 Germany Respiratory Distress Syndrome Market Forecast
10.4.2 France Respiratory Distress Syndrome Market Forecast
10.4.3 UK Respiratory Distress Syndrome Market Forecast
10.4.4 Italy Respiratory Distress Syndrome Market Forecast
10.4.5 Russia Respiratory Distress Syndrome Market Forecast
10.5 Middle East & Africa Respiratory Distress Syndrome Forecast by Region (2025-2030)
10.5.1 Egypt Respiratory Distress Syndrome Market Forecast
10.5.2 South Africa Respiratory Distress Syndrome Market Forecast
10.5.3 Israel Respiratory Distress Syndrome Market Forecast
10.5.4 Turkey Respiratory Distress Syndrome Market Forecast
10.5.5 GCC Countries Respiratory Distress Syndrome Market Forecast
10.6 Global Respiratory Distress Syndrome Forecast by Type (2025-2030)
10.7 Global Respiratory Distress Syndrome Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Information
11.1.2 Chiesi Farmaceutici Respiratory Distress Syndrome Product Offered
11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Chiesi Farmaceutici Main Business Overview
11.1.5 Chiesi Farmaceutici Latest Developments
11.2 CR-Double Crane
11.2.1 CR-Double Crane Company Information
11.2.2 CR-Double Crane Respiratory Distress Syndrome Product Offered
11.2.3 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 CR-Double Crane Main Business Overview
11.2.5 CR-Double Crane Latest Developments
11.3 ONY Biotech
11.3.1 ONY Biotech Company Information
11.3.2 ONY Biotech Respiratory Distress Syndrome Product Offered
11.3.3 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 ONY Biotech Main Business Overview
11.3.5 ONY Biotech Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie Respiratory Distress Syndrome Product Offered
11.4.3 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Yuhan Corporation
11.5.1 Yuhan Corporation Company Information
11.5.2 Yuhan Corporation Respiratory Distress Syndrome Product Offered
11.5.3 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Yuhan Corporation Main Business Overview
11.5.5 Yuhan Corporation Latest Developments
11.6 JW Pharmaceuticals
11.6.1 JW Pharmaceuticals Company Information
11.6.2 JW Pharmaceuticals Respiratory Distress Syndrome Product Offered
11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 JW Pharmaceuticals Main Business Overview
11.6.5 JW Pharmaceuticals Latest Developments
11.7 Noargen
11.7.1 Noargen Company Information
11.7.2 Noargen Respiratory Distress Syndrome Product Offered
11.7.3 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Noargen Main Business Overview
11.7.5 Noargen Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
